Authors:
Li, HF
Gildehaus, FJ
Dresel, S
Patt, JT
Shen, MH
Zhu, T
Liu, B
Tang, ZG
Tatsch, K
Hahn, K
Citation: Hf. Li et al., Comparison of in vivo dopamine D2 receptor binding of [I-123]AIBZM and [I-123]IBZM in rat brain, NUCL MED BI, 28(4), 2001, pp. 383-389
Authors:
Spang, JE
Bertrand, S
Westera, G
Patt, JT
Schubiger, PA
Bertrand, D
Citation: Je. Spang et al., Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptors, CHEM BIOL, 7(7), 2000, pp. 545-555
Authors:
Spang, JE
Patt, JT
Westera, G
Schubiger, PA
Citation: Je. Spang et al., Comparison of N-[C-11]methyl-norchloroepibatidine and N-[C-11]methyl-2-(2-pyridyl)-7-azabicyclo[2.2.1]heptane with N-[C-11]methyl-epibatidine in small animal PET studies, NUCL MED BI, 27(3), 2000, pp. 239-247
Authors:
Patt, JT
Spang, JE
Westera, G
Buck, A
Schubiger, PA
Citation: Jt. Patt et al., Synthesis and in vivo studies of [C-11]N-methylepibatidine: Comparison of the stereoisomers, NUCL MED BI, 26(2), 1999, pp. 165-173
Authors:
Spang, JE
Patt, JT
Westera, G
Schubiger, PA
Citation: Je. Spang et al., Synthesis and [C-11]-radiolabelling of dechloro-epibatidine and 2PABH, twopotential radioligands for studying the central nAChRs in vivo., J LABEL C R, 42(8), 1999, pp. 761-771